
DAF in diabetic patients is subject to glycation/inactivation at its active site residues
Keywords: AGEs; advanced glycation end products; CCP; complement control protein repeat; DAF; decay accelerating factor; GPCR; G protein coupled receptor; DAF; Glycation; Diabetes; Complement; AGE;